Compare PFE & SBUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PFE | SBUX |
|---|---|---|
| Founded | 1849 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.6B | 120.0B |
| IPO Year | 2013 | 1994 |
| Metric | PFE | SBUX |
|---|---|---|
| Price | $25.22 | $101.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 29 |
| Target Price | $29.29 | ★ $104.39 |
| AVG Volume (30 Days) | ★ 25.0M | 7.5M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | ★ 6.55% | 2.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.47 | ★ 0.70 |
| Revenue | ★ $62,579,000,000.00 | $37,184,400,000.00 |
| Revenue This Year | N/A | $4.88 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | ★ $55.29 | $141.87 |
| Revenue Growth | N/A | ★ 2.79 |
| 52 Week Low | $23.11 | $77.99 |
| 52 Week High | $28.75 | $108.88 |
| Indicator | PFE | SBUX |
|---|---|---|
| Relative Strength Index (RSI) | 38.99 | 53.04 |
| Support Level | $25.06 | $82.38 |
| Resistance Level | $26.41 | $104.82 |
| Average True Range (ATR) | 0.46 | 2.67 |
| MACD | 0.02 | 0.42 |
| Stochastic Oscillator | 18.71 | 77.51 |
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Starbucks stands out as the world's biggest and most recognizable coffee brand, powered by ultracustomizable beverages in-store and a sweeping footprint of nearly 41,000 cafes in over 80 countries. About 52% are company-operated, with the balance run by licensees. The company operates roasteries and sells across its North America (74% of revenue as of the end of fiscal 2025), international (21%), and channel development (5%) segments. The brand collects revenue from company-operated stores, licensee royalties, equipment and product sales, retail ready-to-drink beverages, and packaged coffee.